We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FELE:NASDAQFranklin Electric Co., Inc. Analysis

Data as of 2026-06-11 - not real-time

$102.17

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Franklin Electric trades around $102, comfortably above its 20‑day ($98.78) and 50‑day ($99.32) moving averages, with a bullish MACD histogram (+0.35) and a neutral RSI (57), suggesting short‑term momentum remains intact. However, the DCF‑derived fair value of roughly $35 and a forward P/E of 20—well below the industry average of 30—highlight a significant valuation gap, flagging the stock as potentially overvalued. Recent acquisition activity, notably the purchase of Wood Bros, could provide a modest growth catalyst, while the 1.12% dividend yield backed by a 32% payout ratio and solid free cash flow underscores dividend sustainability.
Risk metrics show a beta under 1 (0.85) and 30‑day volatility near 25%, indicating moderate price swings but lower systematic risk. The sector’s cyclical nature and the company’s global footprint introduce medium geographic exposure, yet regulatory and currency risks remain low. Overall, the stock’s price action is near the $103.9 resistance level, with support at $94.96, framing a cautious outlook pending further earnings clarity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term averages but near resistance
  • Bullish MACD yet neutral overall trend
  • Stable volume and low beta limiting downside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Acquisition of Wood Bros could lift earnings growth
  • Forward P/E of 20 suggests improving valuation relative to peers
  • High current price vs DCF fair value keeps upside limited

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustainable dividend with modest payout ratio
  • Consistent revenue growth (~10%) and solid cash generation
  • Valuation gap remains wide, requiring a catalyst for price appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth9.90%
Profit Margin6.91%
P/E Ratio30.8
ROE11.49%
ROA8.95%
Debt/Equity21.61
P/B Ratio3.4
Op. Cash Flow$217.5M
Free Cash Flow$89.4M
Industry P/E30.4

Technical Analysis

TrendNeutral
RSI57.2
Support$94.96
Resistance$103.90
MA 20$98.78
MA 50$99.32
MA 200$97.29
MACDBullish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair Value$35.33
Target Price$113.25
Upside/Downside10.84%
GradeOvervalued
TypeBlend
Dividend Yield1.12%

Risk Assessment

Beta0.85
Volatility24.99%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.